Department of Health and Social Care written question – answered on 8th November 2022.

Alert me about debates like this

Photo of Daisy Cooper Daisy Cooper Liberal Democrat Spokesperson (Health and Social Care), Deputy Leader, Liberal Democrats

To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with the Centre for Disease Control in the US on their use of Evusheld as a pre-exposure prophylaxis to prevent Covid-19 in people who are moderately to severely immunocompromised.

Photo of Will Quince Will Quince Minister of State (Department of Health and Social Care)

The Antivirals and Therapeutics Taskforce has regular engagement with international partners to share learning on the use, deployment and evaluation of therapeutics and antivirals, including Evusheld. The Taskforce recently met with counterparts from the United States of America and discussed the recent change to the Food and Drug Administration’s treatment guidelines, which recommends physicians advise individuals to have appropriate alternate treatment plans in place, should emerging COVID-19 variants be resistant to Evusheld.

We continue monitoring whether and how other countries are using pre-exposure prophylactic treatments in people who are moderately to severely immunocompromised.

Does this answer the above question?

Yes2 people think so

No43 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.